Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXQ4QN
|
||||
| Drug Name |
1-(3-(4-(5-amino-1-(pyridin-2-yl)-1H-1,2,4-triazol-3-ylamino)phenyl)pyrrolidin-1-yl)ethanone
|
||||
| Synonyms |
CHEMBL1835869
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C19H21N7O
|
||||
| Canonical SMILES |
CC(=O)N1CCC(C1)c2ccc(Nc3nc(N)n(n3)c4ccccn4)cc2
|
||||
| InChI |
InChI=1S/C19H21N7O/c1-13(27)25-11-9-15(12-25)14-5-7-16(8-6-14)22-19-23-18(20)26(24-19)17-4-2-3-10-21-17/h2-8,10,15H,9,11-12H2,1H3,(H3,20,22,23,24)
|
||||
| InChIKey |
OEVGYUXYZSTGNX-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | FL cytokine receptor | Target Info | [1587926] | ||
| Mast/stem cell growth factor receptor | Target Info | [1587926] | |||
| KEGG Pathway | Cytokine-cytokine receptor interaction | ||||
| Hematopoietic cell lineage | |||||
| Pathways in cancer | |||||
| Transcriptional misregulation in cancer | |||||
| Acute myeloid leukemia | |||||
| Central carbon metabolism in cancerhsa04014:Ras signaling pathway | |||||
| Rap1 signaling pathway | |||||
| Endocytosis | |||||
| PI3K-Akt signaling pathway | |||||
| Melanogenesis | |||||
| Central carbon metabolism in cancer | |||||
| Pathway Interaction Database | C-MYB transcription factor network | ||||
| Signaling events mediated by Stem cell factor receptor (c-Kit) | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.